AERIE PHARMACEUTICALS INC

CUSIP: 00771V108 Class: COM

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 562,350 Value ($000) $4,218 Avg Close Range
Q1 2022
Shares 589,200 Value ($000) $5,362 Avg Close Range
Q4 2021
Shares 750,000 Value ($000) $5,378 Avg Close Range
Q3 2021
Shares 750,000 Value ($000) $8,550 Avg Close Range
Q2 2021
Shares 750,000 Value ($000) $12,008 Avg Close Range
Q1 2021
Shares 750,000 Value ($000) $13,403 Avg Close Range
Q4 2020
Shares 850,000 Value ($000) $11,484 Avg Close Range
Q3 2020
Shares 850,000 Value ($000) $10,005 Avg Close Range
Q2 2020
Shares 590,000 Value ($000) $8,708 Avg Close Range
Q1 2020
Shares 720,000 Value ($000) $9,720 Avg Close Range
Q4 2019
Shares 700,000 Value ($000) $16,919 Avg Close Range
Q3 2019
Shares 475,000 Value ($000) $9,130 Avg Close Range
Q2 2019
Shares 260,000 Value ($000) $7,683 Avg Close Range
Q1 2019
Shares 260,000 Value ($000) $12,350 Avg Close Range
Q4 2018
Shares 280,000 Value ($000) $10,108 Avg Close Range
Q3 2018
Shares 180,000 Value ($000) $11,079 Avg Close Range
Q2 2018
Shares 70,000 Value ($000) $4,729 Avg Close Range
Q1 2018
Shares 40,000 Value ($000) $2,170 Avg Close Range
Q4 2017
Shares 126,829 Value ($000) $7,578 Avg Close Range
Q3 2017
Shares 120,932 Value ($000) $5,877 Avg Close Range
Q2 2017
Shares 75,000 Value ($000) $3,941 Avg Close Range
Q1 2017
Shares 85,000 Value ($000) $3,855 Avg Close Range
Q4 2016
Shares 35,000 Value ($000) $1,325 Avg Close Range